These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 33361757)

  • 21. Pleckstrin homology (PH) domain and Leucine Rich Repeat Phosphatase 1 (Phlpp1) Suppresses Parathyroid Hormone Receptor 1 (Pth1r) Expression and Signaling During Bone Growth.
    Weaver SR; Taylor EL; Zars EL; Arnold KM; Bradley EW; Westendorf JJ
    J Bone Miner Res; 2021 May; 36(5):986-999. PubMed ID: 33434347
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Kindlin-2 mediates mechanotransduction in bone by regulating expression of Sclerostin in osteocytes.
    Qin L; Fu X; Ma J; Lin M; Zhang P; Wang Y; Yan Q; Tao C; Liu W; Tang B; Chen D; Bai X; Cao H; Xiao G
    Commun Biol; 2021 Mar; 4(1):402. PubMed ID: 33767359
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Conditionally immortalized murine osteoblasts lacking the type 1 PTH/PTHrP receptor.
    Divieti P; Lanske B; Kronenberg HM; Bringhurst FR
    J Bone Miner Res; 1998 Dec; 13(12):1835-45. PubMed ID: 9844101
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mechanisms underlying catabolic and anabolic functions of parathyroid hormone on bone by combination of culture systems of mouse cells.
    Shinoda Y; Kawaguchi H; Higashikawa A; Hirata M; Miura T; Saito T; Nakamura K; Chung UI; Ogata N
    J Cell Biochem; 2010 Mar; 109(4):755-63. PubMed ID: 20058231
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Roles of parathyroid hormone (PTH) receptor and reactive oxygen species in hyperlipidemia-induced PTH resistance in preosteoblasts.
    Li X; Garcia J; Lu J; Iriana S; Kalajzic I; Rowe D; Demer LL; Tintut Y
    J Cell Biochem; 2014 Jan; 115(1):179-88. PubMed ID: 24038594
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Disruption of β-catenin binding to parathyroid hormone (PTH) receptor inhibits PTH-stimulated ERK1/2 activation.
    Yang Y; Wang B
    Biochem Biophys Res Commun; 2015 Aug; 464(1):27-32. PubMed ID: 26047699
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Silencing of parathyroid hormone (PTH) receptor 1 in T cells blunts the bone anabolic activity of PTH.
    Bedi B; Li JY; Tawfeek H; Baek KH; Adams J; Vangara SS; Chang MK; Kneissel M; Weitzmann MN; Pacifici R
    Proc Natl Acad Sci U S A; 2012 Mar; 109(12):E725-33. PubMed ID: 22393015
    [TBL] [Abstract][Full Text] [Related]  

  • 28. RANKL/OPG system regulation by endogenous PTH and PTH1R/ATF4 axis in bone: Implications for bone accrual and strength in growing rats with mild uremia.
    Znorko B; Pawlak D; Oksztulska-Kolanek E; Domaniewski T; Pryczynicz A; Roszczenko A; Rogalska J; Lipowicz P; Doroszko M; Brzoska MM; Pawlak K
    Cytokine; 2018 Jun; 106():19-28. PubMed ID: 29529595
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CCN1/Cyr61 Is Required in Osteoblasts for Responsiveness to the Anabolic Activity of PTH.
    Zhao G; Kim EW; Jiang J; Bhoot C; Charles KR; Baek J; Mohan S; Adams JS; Tetradis S; Lyons KM
    J Bone Miner Res; 2020 Nov; 35(11):2289-2300. PubMed ID: 32634285
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Constitutively active PTH/PTHrP receptor specifically expressed in osteoblasts enhances bone formation induced by bone marrow ablation.
    Ono N; Nakashima K; Schipani E; Hayata T; Ezura Y; Soma K; Kronenberg HM; Noda M
    J Cell Physiol; 2012 Feb; 227(2):408-15. PubMed ID: 21866553
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Per-1 is a specific clock gene regulated by parathyroid hormone (PTH) signaling in osteoblasts and is functional for the transcriptional events induced by PTH.
    Hanyu R; Hayata T; Nagao M; Saita Y; Hemmi H; Notomi T; Nakamoto T; Schipani E; Knonenbery H; Kaneko K; Kurosawa H; Ezura Y; Noda M
    J Cell Biochem; 2011 Feb; 112(2):433-8. PubMed ID: 21268064
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Phospholipase C signaling via the parathyroid hormone (PTH)/PTH-related peptide receptor is essential for normal bone responses to PTH.
    Guo J; Liu M; Yang D; Bouxsein ML; Thomas CC; Schipani E; Bringhurst FR; Kronenberg HM
    Endocrinology; 2010 Aug; 151(8):3502-13. PubMed ID: 20501677
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MMP14 is a novel target of PTH signaling in osteocytes that controls resorption by regulating soluble RANKL production.
    Delgado-Calle J; Hancock B; Likine EF; Sato AY; McAndrews K; Sanudo C; Bruzzaniti A; Riancho JA; Tonra JR; Bellido T
    FASEB J; 2018 May; 32(5):2878-2890. PubMed ID: 29401593
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Down-regulation of human osteoblast PTH/PTHrP receptor mRNA in end-stage renal failure.
    Picton ML; Moore PR; Mawer EB; Houghton D; Freemont AJ; Hutchison AJ; Gokal R; Hoyland JA
    Kidney Int; 2000 Oct; 58(4):1440-9. PubMed ID: 11012879
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lipoatrophy and metabolic disturbance in mice with adipose-specific deletion of kindlin-2.
    Gao H; Guo Y; Yan Q; Yang W; Li R; Lin S; Bai X; Liu C; Chen D; Cao H; Xiao G
    JCI Insight; 2019 Jul; 4(13):. PubMed ID: 31292295
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Arrestins in bone.
    Bohinc BN; Gesty-Palmer D
    Prog Mol Biol Transl Sci; 2013; 118():335-58. PubMed ID: 23764060
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Activated parathyroid hormone/parathyroid hormone-related protein receptor in osteoblastic cells differentially affects cortical and trabecular bone.
    Calvi LM; Sims NA; Hunzelman JL; Knight MC; Giovannetti A; Saxton JM; Kronenberg HM; Baron R; Schipani E
    J Clin Invest; 2001 Feb; 107(3):277-86. PubMed ID: 11160151
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sustained RANKL response to parathyroid hormone in oncostatin M receptor-deficient osteoblasts converts anabolic treatment to a catabolic effect in vivo.
    Walker EC; Poulton IJ; McGregor NE; Ho PW; Allan EH; Quach JM; Martin TJ; Sims NA
    J Bone Miner Res; 2012 Apr; 27(4):902-12. PubMed ID: 22190112
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Osteopontin negatively regulates parathyroid hormone receptor signaling in osteoblasts.
    Ono N; Nakashima K; Rittling SR; Schipani E; Hayata T; Soma K; Denhardt DT; Kronenberg HM; Ezura Y; Noda M
    J Biol Chem; 2008 Jul; 283(28):19400-9. PubMed ID: 18417476
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of intermittent treatment with parathyroid hormone (PTH) on osteoblastic differentiation and mineralization of mouse induced pluripotent stem cells in a 3D culture model.
    Sato M; Aoki H; Nakamura T; Onodera S; Yamaguchi A; Saito A; Azuma T
    J Periodontal Res; 2020 Oct; 55(5):734-743. PubMed ID: 32583900
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.